BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 18266116)

  • 1. Alzheimer's disease sends the wrong signals--a perspective.
    Neve RL
    Amyloid; 2008 Mar; 15(1):1-4. PubMed ID: 18266116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease and Notch signaling.
    Woo HN; Park JS; Gwon AR; Arumugam TV; Jo DG
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1093-7. PubMed ID: 19853579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilin diversifies its portfolio.
    Parks AL; Curtis D
    Trends Genet; 2007 Mar; 23(3):140-50. PubMed ID: 17280736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenilins: how much more than γ-secretase?!
    Coen K; Annaert W
    Biochem Soc Trans; 2010 Dec; 38(6):1474-8. PubMed ID: 21118110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes.
    Shirotani K; Tomioka M; Kremmer E; Haass C; Steiner H
    Neurobiol Dis; 2007 Jul; 27(1):102-7. PubMed ID: 17560791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presenilins: members of the gamma-secretase quartets, but part-time soloists too.
    Wakabayashi T; De Strooper B
    Physiology (Bethesda); 2008 Aug; 23():194-204. PubMed ID: 18697993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular basics of Alzheimer's disease].
    Grigorenko AP; Rogaev EI
    Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presenilin function and gamma-secretase activity.
    Brunkan AL; Goate AM
    J Neurochem; 2005 May; 93(4):769-92. PubMed ID: 15857382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease.
    Zetterberg H
    Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenilins as endoplasmic reticulum calcium leak channels and Alzheimer's disease pathogenesis.
    Supnet C; Bezprozvanny I
    Sci China Life Sci; 2011 Aug; 54(8):744-51. PubMed ID: 21786197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the neuropathology of familial Alzheimer's disease.
    Shepherd C; McCann H; Halliday GM
    Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer's disease.
    Bakshi P; Margenthaler E; Reed J; Crawford F; Mullan M
    Cytokine; 2011 Feb; 53(2):163-9. PubMed ID: 21084199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease.
    Sheng B; Gong K; Niu Y; Liu L; Yan Y; Lu G; Zhang L; Hu M; Zhao N; Zhang X; Tang P; Gong Y
    Free Radic Biol Med; 2009 May; 46(10):1362-75. PubMed ID: 19264123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic mechanisms in Alzheimer's disease.
    Pastorino L; Lu KP
    Eur J Pharmacol; 2006 Sep; 545(1):29-38. PubMed ID: 16904664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of presenilins in cell-survival signalling pathways.
    McCarthy JV
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):568-72. PubMed ID: 16042546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.
    Boo JH; Sohn JH; Kim JE; Song H; Mook-Jung I
    Biochem Biophys Res Commun; 2008 Aug; 372(4):913-7. PubMed ID: 18538664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.